PRKCI and cancer: We previously reported that a PRKCI-ECT2 signaling activity score, calculated from a lung squamous cell carcinoma PKCι-ECT2-signaling-dependent gene signature, predicted poor survival of patients with numerous cancer types, including PDAC [59].